Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms

Anna K Coussens

Open source

DOI
10.1016/s2213-2600(26)00278-x
Published
2026-09
Container
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s2213-2600-26-00278-x,
  title = {Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms},
  author = {Anna K Coussens},
  year = {2026},
  journal = {The Lancet Respiratory Medicine},
  doi = {10.1016/s2213-2600(26)00278-x},
  url = {https://doi.org/10.1016/s2213-2600(26)00278-x}
}

RIS

TY  - JOUR
TI  - Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms
AU  - Anna K Coussens
PY  - 2026
JO  - The Lancet Respiratory Medicine
DO  - 10.1016/s2213-2600(26)00278-x
UR  - https://doi.org/10.1016/s2213-2600(26)00278-x
ER  - 

APA

Coussens, A. K. (2026). Tuberculosis preventive treatment in high-burden settings: inequality in benefit, evidence, and potential harms. The Lancet Respiratory Medicine. https://doi.org/10.1016/s2213-2600(26)00278-x

Source records